“…Generally, portal hypertension is specified as a hepatic venous pressure gradient (HVPG) higher than 5 mm Hg and is frequently seen in chronic viral hepatitis with advanced hepatic fibrosis (METAVIR score . F2) (1,2). It is caused by the combination of increased blood flow through the portal venous system along with increased intrahepatic vascular resistance (3).…”
“…Generally, portal hypertension is specified as a hepatic venous pressure gradient (HVPG) higher than 5 mm Hg and is frequently seen in chronic viral hepatitis with advanced hepatic fibrosis (METAVIR score . F2) (1,2). It is caused by the combination of increased blood flow through the portal venous system along with increased intrahepatic vascular resistance (3).…”
“…It has been even shown to be helpful in assessing reversal of fibrosis following antiviral therapy [48]. Recently, a correlation between HVPG and histologic stages of liver disease has been shown in a study in patients with chronic liver disease due to HBV infection [49]. HVPG can be a good alternative as well as additive to liver biopsy in these patients.…”
Section: Safety and Complications Of Hvpgmentioning
“…A positive correlation between the HVPG and fibrosis score has also been reported among chronically HBV infected patients [172]. HVPG predicted clinical decompensation in patients with compensated cirrhosis.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.